These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34859233)

  • 1. Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies.
    Myall NJ; Yu H; Soltys SG; Wakelee HA; Pollom E
    Neurooncol Adv; 2021 Nov; 3(Suppl 5):v52-v62. PubMed ID: 34859233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases.
    Billena C; Lobbous M; Cordova CA; Peereboom D; Torres-Trejo A; Chan T; Murphy E; Chao ST; Suh J; Yu JS
    Front Oncol; 2023; 13():1110440. PubMed ID: 36910642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer.
    Churilla TM; Weiss SE
    Curr Oncol Rep; 2018 May; 20(7):54. PubMed ID: 29736685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases.
    Moskalenko M; Robin TP
    Transl Cancer Res; 2021 May; 10(5):2527-2536. PubMed ID: 35116569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of systemic precision medicine and immunotherapy treatments on brain metastases.
    Han RH; Dunn GP; Chheda MG; Kim AH
    Oncotarget; 2019 Nov; 10(62):6739-6753. PubMed ID: 31803366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors.
    Wrona A; Dziadziuszko R; Jassem J
    Cancer Treat Rev; 2018 Dec; 71():59-67. PubMed ID: 30366200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases.
    Tonse R; Tom MC; Mehta MP; Ahluwalia MS; Kotecha R
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy for brain metastases.
    Venur VA; Karivedu V; Ahluwalia MS
    Handb Clin Neurol; 2018; 149():137-153. PubMed ID: 29307351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, Treatment, and Complications of Central Nervous System Metastases.
    Pruitt AA
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1580-1600. PubMed ID: 29200112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship.
    Shen CJ; Lim M; Kleinberg LR
    Curr Treat Options Oncol; 2016 Sep; 17(9):46. PubMed ID: 27447703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Systemic Therapy Type and Timing on Intracranial Tumor Control in Patients with Brain Metastasis from Non-Small-Cell Lung Cancer Treated With Stereotactic Radiosurgery.
    Singh SA; McDermott DM; Mattes MD
    World Neurosurg; 2020 Dec; 144():e813-e823. PubMed ID: 32956881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer.
    Bui N; Woodward B; Johnson A; Husain H
    Curr Treat Options Oncol; 2016 May; 17(5):25. PubMed ID: 27085533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy of brain metastases.
    Brastianos HC; Cahill DP; Brastianos PK
    Curr Neurol Neurosci Rep; 2015; 15(2):518. PubMed ID: 25492479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Systemic Treatments for Brain Metastases From Lung Cancer.
    Thapa B; Lauko A; Desai K; Venur VA; Ahluwalia MS
    Curr Treat Options Neurol; 2018 Sep; 20(11):48. PubMed ID: 30259236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Management of Central Nervous System Metastases in Non-Small Cell Lung Cancer.
    D'Aiello A; Miao E; Cheng H
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.
    Moraes FY; Taunk NK; Marta GN; Suh JH; Yamada Y
    Oncologist; 2016 Feb; 21(2):244-51. PubMed ID: 26764249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Cancer Brain Metastases.
    Goldberg SB; Contessa JN; Omay SB; Chiang V
    Cancer J; 2015; 21(5):398-403. PubMed ID: 26389765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed?
    Wrona A
    Cancer Radiother; 2019 Sep; 23(5):432-438. PubMed ID: 31331844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
    Lauko A; Thapa B; Venur VA; Ahluwalia MS
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.